PubRank

J A Wedzicha

Author PubWeight™ 171.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 10.05
2 Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002 8.77
3 Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999 8.63
4 Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 5.49
5 Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993 5.43
6 Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008 5.38
7 Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 5.17
8 Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000 4.45
9 Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002 4.26
10 Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records. BMJ 2013 3.69
11 COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003 3.35
12 COPD exacerbations .1: Epidemiology. Thorax 2006 2.94
13 Arterialised earlobe blood gas analysis: an underused technique. Thorax 1994 2.48
14 Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004 2.24
15 Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 1995 2.20
16 Respiratory medicine: fighting for survival. BMJ 1992 2.15
17 Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000 2.06
18 Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 2007 2.03
19 Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000 2.00
20 Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2006 1.94
21 Relationship between depression and exacerbations in COPD. Eur Respir J 2008 1.81
22 Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003 1.78
23 European union standards for tuberculosis care. Eur Respir J 2012 1.73
24 Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996 1.69
25 Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005 1.67
26 Portable oxygen therapy: assessment and usage. Respir Med 1991 1.66
27 Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998 1.64
28 Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003 1.57
29 Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 1.56
30 Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2009 1.52
31 Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease. Thorax 1999 1.49
32 Using nasal intermittent positive pressure ventilation on a general respiratory ward. J R Coll Physicians Lond 1998 1.48
33 An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Respir Med 1999 1.46
34 Assessment and follow up of patients prescribed long term oxygen treatment. Thorax 1993 1.41
35 MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005 1.37
36 Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004 1.37
37 State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004 1.35
38 Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life. Thorax 1992 1.32
39 Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J 1999 1.27
40 The heterogeneity of chronic obstructive pulmonary disease. Thorax 2000 1.25
41 Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000 1.24
42 Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) 1983 1.23
43 Comparison of pressure and volume preset nasal ventilator systems in stable chronic respiratory failure. Eur Respir J 1993 1.21
44 Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 2001 1.21
45 Sarcoidosis presenting with stroke. Stroke 1989 1.20
46 Is vitamin D deficiency important in the natural history of COPD? Thorax 2010 1.18
47 Small intestinal perforation in Wegener's granulomatosis. Postgrad Med J 1982 1.18
48 Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J 1997 1.17
49 Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J 1996 1.11
50 Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 2005 1.10
51 Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. J Clin Endocrinol Metab 2004 1.09
52 Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J 2010 1.09
53 Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: effect of ventilator mode on arterial blood gas tensions. Thorax 1994 1.05
54 Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation. Br Heart J 1991 1.04
55 Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax 1996 1.00
56 Recent respiratory infection and the risk of myocardial infarction. Heart 2005 0.98
57 What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax 2007 0.98
58 Quality control of equipment in home mechanical ventilation: a European survey. Eur Respir J 2005 0.96
59 Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 0.96
60 Nasal intermittent positive-pressure ventilation in weaning intubated patients with chronic respiratory disease from assisted intermittent, positive-pressure ventilation. Respir Med 1993 0.95
61 Hypoxia and the heart. Br Heart J 1993 0.94
62 Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking. Thorax 1996 0.93
63 Comparison of liquid and gaseous oxygen for domiciliary portable use. Thorax 1992 0.93
64 Recurrent neuroleptic malignant syndrome and hyponatraemia. J Neurol Neurosurg Psychiatry 1986 0.92
65 Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) 1985 0.92
66 Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. Br J Clin Pharmacol 1995 0.92
67 Neuroleptic malignant syndrome and hyponatraemia. Lancet 1984 0.90
68 An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Respir Med 2002 0.90
69 Chorea in digoxin toxicity. J Neurol Neurosurg Psychiatry 1984 0.90
70 Airway epithelial inflammatory responses and clinical parameters in COPD. Eur Respir J 2003 0.90
71 Reviewer selection: author or editor knows best? Thorax 2005 0.90
72 Strategies for improving outcomes of COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2006 0.90
73 Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad Med J 2004 0.89
74 Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003 0.89
75 Chlamydia pneumoniae and COPD exacerbation. Thorax 2002 0.88
76 To publish or perish: how to review a manuscript. Rev Port Pneumol 2011 0.88
77 Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J 2005 0.87
78 Domiciliary oxygen cylinders: indications, prescription and usage. Respir Med 1994 0.87
79 Nasal masks for domiciliary positive pressure ventilation: patient usage and complications. Thorax 1994 0.87
80 Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005 0.85
81 Adverse effects of nasal continuous positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otol 1999 0.85
82 Comparison of nasal pressure support ventilation with nasal intermittent positive pressure ventilation in patients with nocturnal hypoventilation. Eur Respir J 1993 0.84
83 Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005 0.84
84 Ventricular arrhythmia, Cheyne-Stokes respiration, and death: observations from patients with defibrillators. Heart 2005 0.83
85 Ambulatory oxygen therapy in stable kyphoscoliosis. Eur Respir J 1995 0.81
86 Chronic obstructive pulmonary disease past, present and future. Thorax 2007 0.80
87 Domiciliary ventilation in chronic obstructive pulmonary disease: where are we? Thorax 1996 0.79
88 Integrated care: a new model for COPD management? Eur Respir J 2006 0.79
89 Obstructive lung disease in acute medical patients. West Indian Med J 2008 0.79
90 Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung disease. Eur J Respir Dis 1984 0.79
91 Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonale. Clin Sci (Lond) 1986 0.78
92 Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism. Thorax 2007 0.78
93 Ambulatory oxygen in chronic heart failure. Lancet 1992 0.77
94 Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation. Int J Obes Relat Metab Disord 1992 0.76
95 Chronic hypoxia and pulmonary rehabilitation. Thorax 1996 0.75
96 Rehabilitation in severe chronic obstructive pulmonary disease. Lancet 1996 0.75
97 Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002 0.75
98 Inhaled corticosteroids in COPD: a light at the end of the tunnel? Thorax 2005 0.75
99 Apheresis procedures in polycythaemia. Br Med J (Clin Res Ed) 1984 0.75
100 Treatment of pulmonary hypertension in chronic bronchitis and emphysema. Br Med J (Clin Res Ed) 1985 0.75
101 Inhaled corticosteroids in COPD: awaiting controlled trials. Thorax 1993 0.75
102 All change for home oxygen services in England and Wales. Thorax 2006 0.75
103 Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg 1991 0.75
104 LTOT in COPD. Thorax 1994 0.75
105 Pulmonary microvascular permeability in patients with severe mitral stenosis. Br Heart J 1991 0.75
106 Gas transfer for carbon monoxide in polycythaemia secondary to hypoxic lung disease. Clin Sci (Lond) 1985 0.75
107 Nasal ventilation in pregnancy: treatment of nocturnal hypoventilation in a patient with kyphoscoliosis. Eur Respir J 1997 0.75
108 Effects of haematocrit reduction on the haemoglobin-oxygen saturation curve in polycythaemia secondary to hypoxic lung disease. Eur J Respir Dis Suppl 1986 0.75
109 Thorax 2009: another great year! Thorax 2009 0.75
110 Peer review and NICE COPD guidelines. Thorax 2004 0.75
111 Upper airways sarcoidosis presenting as obstructive sleep apnoea. Thorax 1998 0.75
112 Journal impact factors for 2003: Thorax increases. Thorax 2004 0.75
113 Sexually transmitted arthritis? Two informative cases. J Rheumatol 1982 0.75
114 Managing acute on chronic respiratory failure: a guide to non-invasive ventilation. Br J Hosp Med (Lond) 2008 0.75